LoginSignup
COP

Cosmo Pharma

Stock
Stock
ISIN: NL0011832936
Ticker: COPN
NL0011832936
COPN

Price

Price

Historical dividends and forecast

All dividend data

Cosmo Pharma has so far distributed $4.351 in 2024. The next dividend will be paid on 30.05.2025

$2.321

CHART BY

Frequently asked questions

What is Cosmo Pharma's market capitalization?

The market capitalization of Cosmo Pharma is $1.22B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Cosmo Pharma's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Cosmo Pharma is 15.44. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Cosmo Pharma?

Cosmo Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.504. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Cosmo Pharma's stock?

Currently, 5 analysts cover Cosmo Pharma's stock, with a consensus target price of $99.56. Analyst ratings provide insights into the stock's expected performance.

What is Cosmo Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Cosmo Pharma reported a revenue of $193.29M.

What is the EBITDA for Cosmo Pharma?

Cosmo Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $104.93M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Cosmo Pharma?

Cosmo Pharma has a free cash flow of $97.46M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Cosmo Pharma's stock?

The 5-year beta for Cosmo Pharma is 1.64. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Cosmo Pharma have, and what sector and industry does it belong to?

Cosmo Pharma employs approximately 339 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Cosmo Pharma's shares?

The free float of Cosmo Pharma is 7.75M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $1.22B

5Y beta

 1.64

EPS (TTM)

 $4.504

Free Float

 7.75M

P/E ratio (TTM)

 15.44

Revenue (TTM)

 $193.29M

EBITDA (TTM)

 $104.93M

Free Cashflow (TTM)

 $97.46M

Pricing

1D span
$69.47$70.57
52W span
$44.03$94.73

Analyst Ratings

The price target is $99.56 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases and dermatology. Its development pipeline is focused on Bowel Diseases, Colon Infections, and products to reduce the incidence of Colorectal Cancer (CRC) by increasing the detection of cancerous and pre-cancerous lesions during colonoscopy. Products which it has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers’ diarrhoea (TD), Methylene Blue MMX, which is a new diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy and Winlevi for the treatment of acne. Its therapeutic focus is on the oral and endoscopic treatment of colon diseases.

339

Biotechnology & Drugs

Health Care

Identifier

ISIN

NL0011832936

Primary Ticker

COPN

Knockouts

Join the conversation
Sign upLogin